Hannah Deresiewicz
Investor Relations Contact bij FORTY SEVEN, INC.
Profiel
Hannah Deresiewicz is currently working as the Head of Investor Relations at KALA BIO, Inc. and as an Investor Relations Contact at Forty Seven, Inc. She previously worked as a Senior Associate at Stern Investor Relations, Inc. starting in 2013.
Actieve functies van Hannah Deresiewicz
Bedrijven | Functie | Begin |
---|---|---|
FORTY SEVEN, INC. | Investor Relations Contact | - |
KALA BIO, INC. | Investor Relations Contact | - |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-06-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
KALA BIO, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |